ReviewFrontiers in medicine2021
Itch in Scabies-What Do We Know?
Review in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Efficacy and safety of oral ivermectin versus benzyl benzoate for the treatment of scabies: a systematic review and meta-analysis of randomized controlled trials.Frontiers in medicine · 2025Pooled it
- Psychological and behavioral burden of scabies: a comprehensive cross-sectional analysis of pruritus, anxiety, behavioral adaptation, and quality of life.BMC primary care · 2026Article
- Human scabies and pediculosis in Ecuador: spatial distribution and environmental determinants.Parasitology · 2026Article
- Prolonged Post-Scabietic Pruritus: Clinical Characteristics and Unmet Management Needs in a Real-World Cohort.Journal of clinical medicine · 2026Article
- Prevalence and risk factors of scabies among orphans: A cross-sectional study in Bangladesh.PLoS neglected tropical diseases · 2025Article
- Assessing the impact of tungiasis on children's quality of life in Kenya.PLoS neglected tropical diseases · 2025Article
- Effect of ivermectin on scabies: a retrospective evaluation.BMC infectious diseases · 2025Article
- Comparative study of 5% permethrin, 10% neem leaf extract, and 10% brotowali stem extract for scabies treatment.Frontiers in medicine · 2025Article
- Clinical practice guidelines for the diagnosis and treatment of scabies.International journal of dermatology · 2024Review
- Exploring Blood Cell Count-Derived Ratios as Practical Diagnostic Tools for Scabies in Vulnerable Populations.Journal of personalized medicine · 2024Article
- Article
- Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports.Therapeutic advances in chronic disease · 2023Article
- Pruritus as a Distinctive Feature of Type 2 Inflammation.Vaccines · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scabies is a common parasitic skin infestation characterized by severe itch and a heterogenous clinical presentation. Itch, as the cardinal symptom of scabies, is imposing a high burden on affected patients and is often difficult to manage. Decreased life quality and secondary complications, caused by an itch-related disruption of the epidermal barrier and subsequent superinfections, illustrate the need to treat scabies and to understand the underlying mechanisms of itch in respective patients. This review summarizes available data on itch in scabies with a special focus on the clinical aspects and its underlying pathomechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.